Anlon Healthcare Ltd: Stock Analysis & Fundamentals

Updated this week

Anlon Healthcare Ltd (Chemicals - Speciality) — fundamental analysis, earnings data, and key metrics. PE: 21.9. ROE: 40.4%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

💪Debt reduced 13% YoY — balance sheet strengthening

🏛️DII reducing — stake down 1.7%

Key Numbers

Current Price

₹116

Market Cap

616 Cr

Valuation

N/A

← Back to Chemicals - Speciality Dashboard

Frequently Asked Questions: Anlon Healthcare Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Anlon Healthcare Ltd's latest quarterly results?

Anlon Healthcare Ltd's latest quarterly results (Dec 2025) show

PAT Growth YoY: +306.8%
Revenue Growth YoY: +280.1%
Operating Margin: 34.7%

What is Anlon Healthcare Ltd's current PE ratio?

Anlon Healthcare Ltd's current PE ratio is 21.9x.

Current PE: 21.9x
Market Cap: 616 Cr

What is Anlon Healthcare Ltd's price-to-book ratio?

Anlon Healthcare Ltd's price-to-book ratio is 2.9x.

Price-to-Book (P/B): 2.9x
Book Value per Share: ₹40
Current Price: ₹116

Is Anlon Healthcare Ltd a fundamentally strong company?

Anlon Healthcare Ltd's fundamental strength based on key financial ratios

Return on Capital (ROCE): 25.0%

Is Anlon Healthcare Ltd debt free?

Anlon Healthcare Ltd has a debt-to-equity ratio of N/A.

Total Debt: ₹58 Cr

What is Anlon Healthcare Ltd's return on equity (ROE) and ROCE?

Anlon Healthcare Ltd's return ratios over recent years

FY2023: ROCE 15.0%
FY2024: ROCE 15.0%
FY2025: ROCE 25.0%

Is Anlon Healthcare Ltd's cash flow positive?

Anlon Healthcare Ltd's operating cash flow is negative (FY2025).

Cash from Operations (CFO): ₹-23 Cr
Free Cash Flow (FCF): ₹-20 Cr
CFO/PAT Ratio: -110% (weak cash conversion)

What is Anlon Healthcare Ltd's dividend yield?

Anlon Healthcare Ltd currently does not pay a significant dividend (yield 0.00%).

Dividend Yield: 0.00%
Current Price: ₹116

Who holds Anlon Healthcare Ltd shares — promoters, FII, DII?

Anlon Healthcare Ltd's shareholding pattern (Dec 2025)

Promoters: 52.7%
FII (Foreign): 0.2%
DII (Domestic): 4.5%
Public: 42.6%

Is promoter holding increasing or decreasing in Anlon Healthcare Ltd?

Anlon Healthcare Ltd's promoter holding has remained stable recently.

Current Promoter Holding: 52.7% (Dec 2025)
Previous Quarter: 52.7% (Sep 2025)
Change: 0.00% (stable)

Is Anlon Healthcare Ltd a new momentum entry or an established outperformer?

Anlon Healthcare Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Anlon Healthcare Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Anlon Healthcare Ltd may be worth studying

Currently showing mixed signals — monitor for clearer trend confirmation

What is the investment thesis for Anlon Healthcare Ltd?

Anlon Healthcare Ltd investment thesis summary:

What is the future outlook for Anlon Healthcare Ltd?

Anlon Healthcare Ltd's forward outlook based on current data signals

Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.